A study of COVID-19 infection, severity and associated factors among the patients admitted at a tertiary care center in southern Rajasthan
Keywords:COVID 19, India, Infection, Severity
Background: Since December 2019, there has been various outbreaks of corona virus disease 2019 (COVID-19) disease. Whole world is combating this virus, but its reported clinical characteristics as well as outcomes vary greatly amongst studies. This study was conducted to study the clinical features, laboratory findings, comorbidities and severity of the disease among the patients admitted in tertiary care centre in Rajasthan.
Methods: It was a hospital-based cross-sectional study conducted from 1st January 2021 to 30th June 2022 in a tertiary care hospital in Udaipur, Rajasthan. All the patients diagnosed with the help of reverse transcription polymerase chain reaction (RTPCR) for COVID-19, during the study period were included in the study. After taking consent, pre designed questionnaire was used to collect the personal, demographic and clinical information. Radiological, laboratory and mortality data were collected from hospital record.
Results: A total of 400 patients were included in the study. Mean age of the patients was 46.83±17.09 years. Fever (88%) and cough (80%) were the most common symptoms followed by breathlessness (65.8%). About 31.8% (127) patients were found to have severe covid. Severity was found to be significantly associated with increasing age, urban area, breathlessness, co morbidities and D dimer, CRP and IL-6 levels (p value <0.05).
Conclusions: India being a diverse country with a range of sociodemographic characteristics existing within the population, needs a robust approach to control the COVID 19 pandemic. This study presents the factors associated with severe disease and can help to formulate preventive and control strategies.
WHO Coronavirus (COVID 19) Dashboard. Available from: https://covid19.who.int/. Accessed on 26 December 2022.
Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther. 2020;5:84.
Liu T, Zhang J, Yang Y, Ma H, Li Z, Zhang J, et al. The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019. EMBO Mole Med. 2020;12(7):e12421.
Laxminarayan R, Wahl B, Dudala SR, Gopal K, Mohan BC, Neelima S, et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science. 2020;370(6517):691-7.
Prokop M, Van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stöger L, Beenen L, et al. CO-RADS: a categorical CT assessment scheme for patients suspected of having COVID-19- definition and evaluation. Radiology. 2020;296(2):E97-104.
Rajni E, Garg VK, Bacchani D, Sharma R, Vohra R, Mamoria V, et al. Prevalence of bloodstream infections and their etiology in COVID-19 patients admitted in a Tertiary Care Hospital in Jaipur. Indian J Crit Care Med.. 2021;25(4):369.
Verma A, Patyal A, Mathur M, Choudhary S, Mathur N. Sociodemographic and clinical characteristics associated with covid mortality among hospitalized patients in Rajasthan: a retrospective observational study. J Fam Med Prim Care. 2021;10(9):3319.
Bhadra A, Mukherjee A, Sarkar K. Impact of population density on COVID-19 infected and mortality rate in India. Model Earth Syst Environ. 2020;14:1-7.
Mohan A, Tiwari P, Bhatnagar S, Patel A, Maurya A, Dar L, et al. Clinico-demographic profile and hospital outcomes of COVID-19 patients admitted at a tertiary care center in north India. Indian J Med Res. 2020;152:61.
Bhandari S, Singh A, Sharma R, Rankawat G, Banerjee S, Gupta V, et al. Characteristics, Treatment outcomes and role of hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An epidemio-clinical study. J Assoc Phys India. 2020;68:13-9.
Rivera-Izquierdo M, del Carmen Valero-Ubierna M, R-delAmo JL, Fernández-García MÁ, Martínez-Diz S, Tahery-Mahmoud A, et al. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study. PLoS One. 2020;15:e0235107.
Shi L, Wang Y, Wang Y, Duan G, Yang H. Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19. J Infect. 2020;81:647-79.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.
Johnson MJ, Close L, Gillon SC, Molassiotis A, Lee PH, Farquhar MC, et al. Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis. Eur Respir J. 2016;47(6):1861-4.
Hentsch L, Cocetta S, Allali G, Santana I, Eason R, Adam E, et al. Breathlessness and COVID-19: a call for research. Respiration. 2021;100(10):1016-26.
Radwan NM, Mahmoud NE, Alfaifi AH, Alabdulkareem KI. Comorbidities and severity of coronavirus disease 2019 patients. Saudi Med J. 2020;41(11):1165.
Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Med J. 2020;133(09):1032-8.
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;75(7):1730-41.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
Lippi G, Wong J, Henry BM. Hypertension and its severity or mortality in coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130:304-9.
Broman N, Rantasärkkä K, Feuth T, Valtonen M, Waris M, Hohenthal U, et al. IL-6 and other biomarkers as predictors of severity in COVID-19. Ann Med. 2021;53(1):410-2.
Eljilany I, Elzouki AN. D-dimer, fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: a narrative review. Vasc Health Risk Manage. 2020;16:455.
Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, et al. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early. J Med Virol. 2020;92(7):856-62.